Consumer Health Healthcare
Lakewood Amedex Advances Nu 3 Bisphosphocin Candidate With Strong AMR Resistance Profile
Nu-3 represents a novel class of potent, fast-acting, broad-spectrum antimicrobials called Bisphosphocins® Lakewood-Amedex Biotherapeutics Inc., (NASD...
May 02, 2026 | News
Henlius And Organon Secure European Approval For First Pertuzumab Biosimilar POHERDY
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHE...
May 01, 2026 | News
Acrux Advances Female Testosterone Therapy To Phase III To Address HSDD Treatment Gap
Massive unmet need for Hypoactive Sexual Desire Disorder treatments addressed by new Female Testosterone product Phase I and II clinical trials complete...
April 30, 2026 | News
IMG Pharmaceutical Co Ltd To Acquire Matsumoto Pharmaceutical Co Ltd To Strengthen Integrated Healthcare Platform
IMG Pharmaceutical Co., Ltd. ("IMG Pharma"), a majority-owned subsidiary of IMG Japan, the Group's holding company, announced that it has entered into a de...
April 29, 2026 | News
Cellenkos Inc. Receives U.S. Food and Drug Administration Clearance To Advance CK0801 Phase 2 Trial In Aplastic Anemia
Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs in transfusion-dependent aplastic anemia...
April 29, 2026 | News
Cerapedics Expands US Market Access Through Vizient Agreement For PearlMatrix Bone Graft
Agreement expands access to the Cerapedics portfolio of peptide-powered drug-device products for spinal fusion procedures Cerapedics Inc., a global, comme...
April 27, 2026 | News
Medtronic Advances Affera Cardiac Ablation Platform With Strong VT Outcomes And Expanded Clinical Trials
HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained mo...
April 27, 2026 | News
Ascletis Completes Enrollment For Phase II Study Of Oral GLP 1R Agonist ASC30 In Type 2 Diabetes
- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-d...
April 27, 2026 | News
Amcor Invests $35 Million To Expand Advanced Healthcare Packaging Capabilities In Malaysia
A $35 million USD investment brings advanced air-knife coating technology and sterile medical packaging capabilities to Southeast Asia, further strengtheni...
April 27, 2026 | News
Dawn Medical Technologies Enters Vietnam With Pinnacle Health Acquisition
Strategic entry into high-growth Vietnam market Combines Dawn's product sourcing capabilities with Pinnacle Health's established local presence and mark...
April 23, 2026 | News
SynbioTech Probiotic Strain Shows Potential In Uric Acid Regulation Through Multi Mechanism Action
SynbioTech announced that its Lactiplantibacillus plantarum FS4722 (L. plantarum FS4722), a probiotic strain isolated from traditional Chine...
April 23, 2026 | News
NOVI Health Study Shows Integrated GLP One And Digital Coaching Achieve Clinical Grade Weight Loss Outcomes
An estimated ~14.7% weight loss at 18 months was achieved in one of the first studies evaluating integrated GLP-1 therapies and di...
April 23, 2026 | News
Dayspring Pharma Reports Positive Phase II Results For CG2001 In Androgenetic Alopecia
Dayspring Pharma announced top-line data from its Phase II clinical trial of CG2001 foam in male patients with androgenetic alopecia (AGA). The trial ...
April 23, 2026 | News
Can AI close the MSK inequality gap? Improving access to musculoskeletal care in the UK
Behind these statistics lies a deeper and more troubling social divide: that the greatest burden is carried by those in our most deprived communities and m...
April 14, 2026 | Opinion | By Peter Grinbergs, Chief Medical Officer and Co‑founder of EQL
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
